Virginia Commonwealth University

PHILADELPHIA — Hepatologists and gastroenterologists must be internal medicine physicians, not just specialists, to determine the root cause of complaints in patients with suspected hepatic encephalopathy, according to an expert.

Atrial fibrillation is a complex disease with ever-increasing treatment options, such as ablation, and advanced electrophysiology fellowship training is key to improving long-term outcomes, according to a new consensus statement.

Tirzepatide and semaglutide confer greater weight loss than other FDA-approved obesity medications with no significantly higher risk for adverse events, according to findings from a network meta-analysis published in Obesity.

Robert A. Winn, MD, FAACR, first called for celebration.

When Robert A. Winn, MD, learned he’d receive the Allen Lichter Visionary Leader Award at this year’s ASCO Annual Meeting, he reacted in the form of a question: “What just happened?”

The prospect of screening for multiple cancer types simultaneously through a blood draw or other simple methods has generated tremendous excitement.

Patients not required to fast before cardiac catheterization reported higher overall postprocedural satisfaction with no periprocedural adverse events, a speaker reported.

Providers should focus more on using pharmacotherapies in addition to lifestyle intervention to prevent progression from prediabetes to type 2 diabetes, according to two researchers.

Adolescent and young adult survivors of kidney cancer appeared at significantly increased risk for left ventricular ejection fraction, according to study results published in Journal of the National Comprehensive Cancer Network.

SAN DIEGO — In this video, Megan Lemay, MD, an associate professor of general internal medicine and addiction medicine at Virginia Commonwealth University, highlights several sessions from the ACP Internal Medicine Meeting.